Compare STRL & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STRL | ASND |
|---|---|---|
| Founded | 1955 | 2006 |
| Country | United States | Denmark |
| Employees | 1740 | N/A |
| Industry | Military/Government/Technical | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.4B | 13.6B |
| IPO Year | 1996 | 2014 |
| Metric | STRL | ASND |
|---|---|---|
| Price | $417.13 | $230.68 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 15 |
| Target Price | ★ $443.33 | $278.80 |
| AVG Volume (30 Days) | 493.4K | ★ 662.8K |
| Earning Date | 05-28-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 13.42 | N/A |
| EPS | ★ 9.38 | N/A |
| Revenue | ★ $957,958,000.00 | N/A |
| Revenue This Year | $20.76 | $98.02 |
| Revenue Next Year | $11.64 | $43.13 |
| P/E Ratio | $42.44 | ★ N/A |
| Revenue Growth | ★ 38.81 | N/A |
| 52 Week Low | $96.34 | $124.06 |
| 52 Week High | $477.03 | $248.60 |
| Indicator | STRL | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 53.56 | 50.50 |
| Support Level | $385.44 | $190.49 |
| Resistance Level | $419.14 | $245.30 |
| Average True Range (ATR) | 24.15 | 9.13 |
| MACD | -4.39 | -1.46 |
| Stochastic Oscillator | 42.44 | 38.67 |
Sterling Infrastructure Inc is a construction company that specializes in heavy civil infrastructure construction and infrastructure rehabilitation as well as residential construction projects. The company operates in three reportable segments namely, Transportation Solutions, E-Infrastructure Solutions, and Building Solution. Transportation Solutions include highways, roads, bridges, airfields, ports, light rail, and others. Building Solution projects include concrete foundations for single-family homes. E-Infrastructure Solutions include the services which are provided to large, blue-chip companies in the e-commerce, data center, distribution center, and warehousing, energy, mixed-use, and multi-family sectors. The majority of the revenue is generated from E-Infrastructure Solutions.
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.